Recent research from Australia has revealed alarming evidence that vaping is associated with significant alterations in the body that may heighten the risk of developing lung and oral cancers. The study, spearheaded by the University of New South Wales, underscores the pressing need for regulatory bodies to respond proactively to these findings rather than waiting for conclusive long-term data.
Emerging Evidence of Carcinogenic Changes
The comprehensive review, published in the journal *Carcinogenesis*, analysed a range of studies conducted between 2017 and 2025, encompassing animal research, human case reports, and laboratory data. The researchers found early indicators of cancer risk linked to vaping, such as DNA damage and inflammation. Co-author Adjunct Professor Bernard Stewart noted, “There is no doubt that the cells and tissues of the oral cavity, the mouth, and the lungs are altered by inhalation from e-cigarettes.” These biological changes are precursors often associated with cancer development.
The review did not attempt to quantify the cancer risk posed by vaping due to the relatively recent emergence of e-cigarettes, which have been in use since the early 2000s. This lack of longitudinal data, particularly concerning large populations that vape exclusively, complicates efforts to delineate the specific impact of vaping from that of traditional tobacco smoking.
Case Reports and Animal Studies
Notably, the research included observations from dental professionals who reported instances of oral cancer in patients who had exclusively used e-cigarettes without prior smoking history. Additionally, animal studies were referenced, indicating that mice exposed to e-cigarette vapour experienced a higher incidence of lung tumours compared to unexposed counterparts. However, as Stewart cautioned, such findings in animals do not always have direct implications for human health.
Despite the challenges in establishing definitive causal links, the authors concluded that e-cigarettes could likely contribute to both lung and oral cancers, although the extent of this potential burden remains uncertain. Lead author Associate Professor Freddy Sitas highlighted the historical context, recalling how it took decades for the medical community to unequivocally link smoking with lung cancer. “We risk repeating that same fate with vaping if we don’t take emerging research and warning signs seriously,” he warned.
The Call for Regulatory Response
As the evidence mounts, experts are urging health authorities and policymakers to take decisive action to protect public health. Calvin Cochran, a research fellow at the University of Otago, emphasised the importance of considering every study seriously to avoid a repeat of past oversights. “Every study like this should be considered seriously by policymakers, governments, and health organisations,” he stated, highlighting the potential long-term consequences of inaction.
Professor Stephen Duffy from Queen Mary University London cautioned against equating the dangers of vaping with those of smoking, noting that vaping lacks exposure to the combustion products found in traditional tobacco. Nonetheless, Stewart contended that vaping must be assessed on its own merits, particularly regarding its potential to induce cancer.
Professor Becky Freeman, a tobacco control researcher at the University of Sydney, reinforced the study’s claims, stating, “This study is the first to assert that there is likely an increased cancer risk for people who vape, compared to people who do not vape.” She stressed the implications of these findings for young people who have never smoked, reiterating that vaping should not be viewed as a safe alternative to smoking.
Why it Matters
The implications of this research are profound, particularly for the younger demographic increasingly drawn to vaping. As the evidence mounts linking e-cigarettes to significant health risks, it becomes essential for regulation to keep pace. Allowing access to vaping products without stringent oversight could lead to a public health crisis reminiscent of the smoking epidemic. To safeguard future generations, it is imperative that regulators act decisively, ensuring that vaping is not mistakenly viewed as a benign alternative to smoking.
